MACOM Technology Solutions (MTSI) CFO sells 7,196 shares in 10b5-1 plan

Rhea-AI Filing Summary

MACOM Technology Solutions Holdings, Inc. Senior VP and CFO John Kober reported a series of open-market sales of common stock. On February 17, 2026, he sold a total of 7,196 shares at prices generally between about $236 and $248 per share under a pre-arranged Rule 10b5-1 trading plan adopted on August 14, 2025. After these transactions, he directly held 48,508 shares of MACOM common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kober John

(Last) (First) (Middle)

C/O MACOM TECHNOLOGY SOLUTIONS HOLDINGS

100 CHELMSFORD STREET

(Street)

LOWELL MA 01851

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MACOM Technology Solutions Holdings, Inc. [ MTSI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Senior VP and CFO

3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/17/2026		S(1)		200	D	$236.42(2)	55,504	D
Common Stock	02/17/2026		S(1)		300	D	$237.68(3)	55,204	D
Common Stock	02/17/2026		S(1)		500	D	$238.71(4)	54,704	D
Common Stock	02/17/2026		S(1)		200	D	$239.83(5)	54,504	D
Common Stock	02/17/2026		S(1)		2,223	D	$241.09(6)	52,281	D
Common Stock	02/17/2026		S(1)		133	D	$243.38(7)	52,148	D
Common Stock	02/17/2026		S(1)		767	D	$244.73(8)	51,381	D
Common Stock	02/17/2026		S(1)		1,753	D	$245.55(9)	49,628	D
Common Stock	02/17/2026		S(1)		600	D	$246.63(10)	49,028	D
Common Stock	02/17/2026		S(1)		520	D	$247.7(11)	48,508	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares were sold pursuant to a sales plan adopted by the Reporting Person on August 14, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $236.00 to $236.84. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $237.17 to $237.93. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $238.65 to $238.76. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote

5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $239.75 to $240.00. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $241.05 to $241.54. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

7. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $243.14 to $244.13. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

8. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $244.14 to $244.99. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

9. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $245.26 to $245.98. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

10. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $246.40 to $247.24. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

11. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $247.49 to $248.02. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

	/s/ Ambra R. Roth, Attorney-in-Fact	02/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did MACOM (MTSI) report for John Kober?

MACOM’s Senior VP and CFO John Kober reported selling 7,196 shares of common stock. The sales occurred in multiple open-market transactions, reflecting routine insider trading disclosure rather than any company-level financing or new share issuance.

When did the MACOM (MTSI) CFO sell his shares and at what prices?

The CFO’s sales took place on February 17, 2026, in several open-market trades. Footnotes state the weighted-average sale prices came from ranges spanning roughly $236.00 to $248.02 per share across different transaction groups.

How many MACOM (MTSI) shares did the CFO sell in total?

Across ten separate transactions, the CFO sold a total of 7,196 MACOM common shares. These were reported as non-derivative, open-market sales, with each line item showing the shares sold and the weighted-average sale price for that transaction group.

How many MACOM (MTSI) shares does the CFO hold after these sales?

Following the reported transactions, the filing shows the CFO directly holding 48,508 MACOM common shares. This figure reflects his ownership after all ten sale entries on February 17, 2026, as disclosed in the Form 4 summary columns.

Were the MACOM (MTSI) CFO’s stock sales under a 10b5-1 plan?

Yes. A footnote explains the shares were sold under a Rule 10b5-1 trading plan. That plan was adopted on August 14, 2025, allowing pre-scheduled sales intended to comply with insider trading regulations under the Securities Exchange Act of 1934.

Did the MACOM (MTSI) Form 4 mention weighted-average sale prices?

Yes. Multiple footnotes clarify that the prices reported are weighted averages for each transaction line. They note the shares were sold in numerous trades within specified price ranges and that detailed trade-level data is available upon request.